Patients with late-stage lung and skin cancer may have just won an unlikely ally: the COVID-19 mRNA vaccine. Researchers at ...
Over the last year, Noubar Afeyan has watched Cambridge-based Moderna go from perhaps the world’s most celebrated company ...
To tailor cancer therapies to individual patients, Moderna, BioNTech and other companies are rethinking how they optimize ...
The mRNA technology that helped combat the global COVID-19 pandemic may now offer new hope in the fight against cancer, ...
Multilateral initiatives are needed to signal confidence and fill funding gaps in mRNA research, writes Jennifer B Nuzzo ...
Patients with an aggressive form of breast cancer will likely have new treatment options after AstraZeneca and Gilead ...
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large ...
Health and Me on MSN
Could Covid-19 Vaccine Make Cancer Patients Live Longer?
Vaccine Linked to Longer Survival in Cancer Patients,” found that people with advanced lung or skin cancer who received an ...
Company seeks strategic partners to advance novel PlaCCine technology LAWRENCEVILLE, N.J., Oct. 17, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company focused on developing ...
The researchers argue that traditional vaccine development methods, which rely heavily on laboratory experimentation and long ...
Jeffrey Tucker, who elevated Covid contrarians now working for the health secretary, is building support for Kennedy’s Make ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback